Omega Funds
Omega Funds is a venture capital firm dedicated to investing in the future of medicine. The firm focuses on supporting exceptional founders and entrepreneurs in developing impactful products and platforms across various therapeutic areas, including oncology, immunology, rare diseases, and precision medicine. Omega Funds aims to bring science to patients by investing in innovative solutions that address significant medical needs.
Omega Funds
Portfolio
SoniVie raised $60 million in Round C financing and appointed new board members.
#Medical Devices
NRG Therapeutics announced a £16 million Series A to advance mitochondrial therapeutics for Parkinson’s and ALS.
#Biotechnology
Regeneron is set to acquire Checkmate Pharmaceuticals and its investigational immune activator for potential use in multiple tumor types.
#Biotechnology
Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats.
#Biotechnology
Sanofi is set to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics.
#Biotechnology
Merck acquires Chord Therapeutics to expand its neuroinflammatory pipeline.
#Biotechnology
Developing best-in-class antibodies that can broadly neutralize SARS-CoV-2 and additional pre-emergent coronaviruses.
#Biotechnology
Developing next generation thrombectomy systems for the treatment of ischemic stroke.
#Medical Devices
A complete software ecosystem for manual pipetting, light automation and full automation.
#Research Tools
Developing a new generation of genetic medicines to overcome the greatest challenges facing the field.
#Biotechnology
Designs, manufactures and customizes biological wastewater treatment solutions.
#Environmental
Developing and commercializing treatments for immune-mediated dermatological diseases.
#Pharmaceuticals
Building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines.
#Biotechnology
Developing breakthrough cancer treatments that target DNA Damage Response pathways to specifically destroy certain devastating cancers that are difficult to treat.
#Biotechnology
Pioneering the use of base editing for life-long cures to patients suffering from serious diseases.
#Biotechnology
Developing innovative diabetes management solutions, including the iLet Bionic pancreas insulin pump.
#Medical Devices
Developing a first-in-class bifunctional antibody to elicit a potent and durable anti-tumor response.
#Biotechnology
Focused on clinical development of antibody drugs for immunotherapy against cancer.
#Biotechnology
Develops innovative, reagent-based bacterial and yeast expression culture systems.
#Biotechnology
Developer of biologics for the treatment of cancer and prevention of infectious diseases.
#Biotechnology
Advancing programmable epigenetic editors that harness innate mechanisms to precisely control gene expression.
#Biotechnology
Focused on the discovery, development, and commercialization of novel anti-infectives.
#Biotechnology
Provider of agronomic traits for the commercial seed markets in Belgium and internationally.
#Agriculture
Developer of drugs that are intended to treat serious metabolic disorders.
#Biotechnology
Develops therapies for metabolic disorders based on model organisms and stem cell expertise.
#Biotechnology
Involved in the discovery and development of innovative treatments for rare inherited diseases.
#Biotechnology
Treating patients with genetically defined diseases by correcting disease-causing genes.
#Biotechnology
Focused on the commercialization and development of abuse-resistant opioid formulations.
#Pharmaceuticals
Developing new treatments targeting the underlying causes of pulmonary fibrosis.
#Biotechnology
Novel gene therapy platform delivering non-viral treatments to mucosal tissues and organs.
#Biotechnology
Molecular diagnostics company focused on blood testing for the early detection of cancer.
#Biotechnology
Developing and commercializing a treatment for anemia associated with chronic kidney disease.
#Biotechnology
Selectively targeting disease-causing immune cells to treat inflammatory diseases.
#Biotechnology
Drugging key molecular targets involved in DNA replication stress, towards the development of targeted anticancer drugs.
#Biotechnology
Focused on therapeutics in the disease areas of immunology, inflammation, and oncology.
#Biotechnology
Focused on research and development of new targets and therapies against cancer.
#Biotechnology
Developing safe and effective vaccines against infectious diseases that cause severe, life-threatening respiratory illnesses.
#Biotechnology
Developer of small molecules that modulate novel targets in the innate immune system.
#Biotechnology
Developing breakthrough targeted oncology and immunometabolism therapies for difficult to treat cancers.
#Biotechnology
Developing selective therapies aimed at treating chronic inflammatory and autoimmune diseases.
#Biotechnology
Developing biological drugs to treat cancer, infectious diseases and autoimmune diseases using soluble T-cell receptor technology.
#Biotechnology
Developing innovative therapies utilizing a proprietary delivery system.
#Biotechnology
Developing therapies that enable the immune system to attack tumors.
#Biotechnology
Focused on developing cellular immunotherapies for the treatment of cancer.
#Biotechnology
Developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
#Biotechnology
Focused on the development of a new class of bio-pharmaceutical products.
#Biotechnology
Focused on discovering and developing gene therapy treatments and cures to some of today's most devastating diseases.
#Biotechnology
Developer of proprietary antibodies to treat cancer, inflammation and autoimmune diseases.
#Biotechnology
Focused on the characterization and development of innovative drugs in autoimmune diseases.
#Biotechnology
Focused on developing a pipeline of oral small-molecule integrin therapeutics.
#Biotechnology
Developer of a novel therapy system designed in the treatment of a broad array of eye diseases.
#Biotechnology
Developer of retinal imaging technology intended to offer early detection of Alzheimer's disease.
#Biotechnology
Focused on the development of therapies for patients with diseases of the nervous system.
#Biotechnology
Developer of novel pharmaceuticals products for the treatment of heart failure.
#Pharmaceuticals
Developer of biological products designed to provide treatment of neurological diseases.
#Biotechnology
Developing next generation therapies that will target the foremost unmet needs in oncology.
#Biotechnology
Focused on therapeutics for serious conditions that compromise a woman's reproductive health.
#Biotechnology
Blank check company targeting biotechnology companies in the United States and Europe.
#Biotechnology
Developer of small molecule drugs designed to treat inflammatory and respiratory diseases.
#Biotechnology
Developing and commercializing medical innovations for procedural sedation and anesthesia.
#Pharmaceuticals
Development and commercialization of novel therapies for life-threatening diseases.
#Pharmaceuticals
Development and commercialization of drugs using the electrostatic deposition technology.
#Pharmaceuticals
Proprietary bifunctional small molecules platform which unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms.
#Biotechnology
Developing and commercializing gene therapies for patients with neurodegenerative diseases.
#Biotechnology
Engaged in the development of novel pharmaceuticals for renal and vascular disease.
#Biotechnology
Developing disease-modifying precision therapeutics that restore ABC transporter function for patients with serious genetic diseases.
#Biotechnology
Developing drugs to maximally activate the immune system against solid tumors.
#Biotechnology
Pioneering the discovery and development of small molecule, tumor-agnostic therapies.
#Biotechnology
Developer of novel therapeutics designed to deliver more precise treatments.
#Biotechnology
Developing first-in-class, targeted, topical products in medical dermatology and aesthetics.
#Biotechnology
Utilizes its peptide platform technologies to develop treatments for a wide range of illnesses.
#Biotechnology
Developing and marketing of implants and instrumentation for spinal treatment.
#Medical Devices
Developing pioneering medicines for the treatment of myeloproliferative diseases.
#Biotechnology
An engineered cytokine therapeutics company developing disease-optimized treatments.
#Biotechnology
Developing transformational therapeutics for the treatment of serious human diseases.
#Biotechnology
Developing best-in-class kinase inhibitors to shape the future of targeted oncology.
#Biotechnology
Developing medicines to treat diseases caused by protein or gene dysfunction.
#Biotechnology
Development and commercialization of nalbuphine ER to treat serious neurological conditions.
#Biotechnology
Focused on discovering and developing next-generation medicines for neurodegenerative diseases.
#Biotechnology
Developing innovative antibody-based therapies for the treatment of kidney diseases.
#Biotechnology
Developer and manufacturer of fibrin based hemostasis and surgical sealant products.
#Medical Devices
Key People
Managing Director